rituximab,cyclophosphamide
roche,biogen
['ritux', 'imab ']
#acr22-prof. dan furst interview dr. alessandro tomelleri, eustar young investigator member, interview at prof. daniel furst on : rituximab vs cyclophophamide for the treatment of ctd 
The World Scleroderma Foundation is a non-profit, non-governmental foundation based in Switzerland, promoting scleroderma research and supporting patients.